Incretin Atlas › Trials › SLIMMER
SLIMMER
Ecnoglutide · obesity
Design
- Molecule(s)
- Ecnoglutide
- Population
- obesity
- Official title
- A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Phase
- 3
- Registry status
- completed · 2023-04 → 2024-06
- Participants
- 664
- Duration
- 48 weeks
- Registry
- NCT05813795
Results by arm
| Arm | Population | Weeks | n | Weight, efficacy | Weight, treatment-policy | HbA1c, pp | AE discontinuation, % | Any discontinuation, % | Nausea, % | Vomiting, % | SAE, % | SBP, mmHg | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 mg | obesity china | 48 | 664 | — | −9.9 % vs −0.3 % Δ −9.6 pp | — | — | — | — | — | — | — | press release |
| 1.8 mg | obesity china | 48 | 664 | — | −13.3 % vs −0.3 % Δ −13.0 pp | — | — | — | — | — | — | — | press release |
| 2.4 mg | obesity china | 48 | 664 | — | −15.4 % vs −0.3 % Δ −15.1 pp | — | — | — | — | — | — | — | press release |
Weight: percent change from baseline, drug vs placebo or comparator, Δ = difference in percentage points. Efficacy estimand = effect while on treatment (hypothetical strategy); treatment-policy = all randomised participants regardless of adherence (ITT). AE discontinuation = stopped study drug for any adverse event. Hover a status for its definition.
Verbatim quotes from the source (3)
- 1.2 mg · weight_tp · press release
Percent weight reduction, % | -9.9 | -13.3 | -15.4 | -0.3
- 1.8 mg · weight_tp · press release
Percent weight reduction, % | -9.9 | -13.3 | -15.4 | -0.3
- 2.4 mg · weight_tp · press release
Percent weight reduction, % | -9.9 | -13.3 | -15.4 | -0.3
Primary sources
- Sciwind. Sciwind Biosciences Announces Publication of Phase III SLIMMER Trial Results in The Lancet Diabetes & Endocrinology (BioPharma Dive mirror of company release) [press release]. 2025-06-21. Available from: https://www.biopharmadive.com/press-release/20250621-sciwind-biosciences-announces-publication-of-phase-iii-slimmer-trial-result-1
- ClinicalTrials.gov NCT05813795
How to cite this page
Medical Adviser's Group. Incretin Atlas: SLIMMER. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/trials/slimmer/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.
Cite the primary publication for any single result; every value above links to it.